BissellBDMageeCMoranPBastinMLTFlanneryAH. Hemodynamic instability secondary to vasopressin withdrawal in septic shock [published online January 1, 2017]. J Intensive Care Med. 2017.
2.
RussellJAWalleyKRSingerJ. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887.
3.
SharsharTBlanchardAPaillardMRaphaelJCGajdosPAnnaneD. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31(6):1752–1758.
4.
SharsharTCarlierRBlanchardA. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30(3):497–500.
5.
HammondDAMcCainKPainterJT. Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock [published online January 1, 2017]. J Intensive Care Med. 2017.
6.
LevineARMeyerMJBittnerEA. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions. J Crit Care. 2013;28(5):756–762.
7.
WhitsonMRMoENabiT. Feasibility, utility, and safety of midodrine during recovery phase from septic shock. Chest. 2016;149(6):1380–1383.
8.
HammondDASmithMNMeenaN. Considerations on midodrine use in resolving septic shock. Chest. 2016;149(6):1582–1583.
9.
BihariDPrakashSBerstenA. Low-dose vasopressin in addition to noradrenaline may lead to faster resolution of organ failure in patients with severe sepsis/septic shock. Anaesth Intensive Care. 2014;42(5):671–674.
10.
ReardonDPDeGradoJRAngerKESzumitaPM. Early vasopressin reduces incidence of new onset arrhythmias. J Crit Care. 2014;29(4):482–485.
11.
HammondDACullenJPainterJT. Efficacy and safety of the early addition of vasopressin to norepinephrine in septic shock [published online January 1, 2017]. J Intensive Care Med. 2017.
